From Bench to Bedside: Targeting Signalling Pathways in CLL

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

ERIC 2022 - European Research Initiative on CLL - ERIC

http://www.ericll.org/

Videos

Playback speed

10 seconds

From Bench to Bedside: Targeting Signalling Pathways in CLL

By ERIC 2022 - European Research Initiative on CLL - ERIC FEATURING Jennifer Brown

16 views

November 8, 2022

Comments 0

New Approval for Frontline Consolidation in Patients with CD19-posit…

Feat. J. Mccloskey

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison

Videos

My Vision of the Future of CLL

ERIC 2022 - European Research Initiative on CLL - ERIC

K. Rai

97 views

Outcomes of Patients With CLL and COVID-19 Infection

ERIC 2022 - European Research Initiative on CLL - ERIC

T. Chatzikonstantinou

77 views

Outcomes of SARS-CoV-2 Vaccination in Patients with CLL

ERIC 2022 - European Research Initiative on CLL - ERIC

Y. Herishanu

44 views

Practical Considerations on COVID-19 Management in Patients With CLL

ERIC 2022 - European Research Initiative on CLL - ERIC

A. Cuneo

19 views

The CLL Microenvironment

ERIC 2022 - European Research Initiative on CLL - ERIC

T. Hartmann

38 views

Cellular Therapies in CLL: Present and Future

ERIC 2022 - European Research Initiative on CLL - ERIC

M. Ruella

25 views

Round Table Discussion: Optimizing Treatment Outcomes in CLL

ERIC 2022 - European Research Initiative on CLL - ERIC

C. Moreno, B. Eichhorst, J. Seymour, A. Kater, T. Kipps

29 views

The Molecular Basis of Resistance to Treatment in CLL

ERIC 2022 - European Research Initiative on CLL - ERIC

T. Zenz

58 views